Approved for ELIGARD is indicated for the treatment of advanced prostate cancer.. Leuprolide acetate, a gonadotropin releasing hormone (GnRH) agonist, acts as an inhibitor of gonadotropin secretion when given continuously in therapeutic doses. Animal and human studies indicate… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and…
Loading full data from Know Your Drugs Institute…